This drug focuses on the root cause of diabetes, offering a different approach from current symptomatic treatments. It aims for complete healing of the patient, giving it a competitive edge. Specifically, the drug acts directly on the root cause of diabetes, especially targeting the abnormal stem cells believed to trigger the disease, with the goal of normalizing them. This aims to resolve diabetes and its complications fundamentally, significantly improving patients’ quality of life. It represents a new approach different from existing treatments, potentially enabling a complete cure for diabetes.